Post #16: Download your brain

What you are about to read is not from the pages of a science fiction paperback, but a summary of a fascinating report published in Nature last week. In brief…

Post #16: Download your brain

What you are about to read is not from the pages of a science fiction paperback, but a summary of a fascinating report published in Nature last week. In brief, scientists have developed a new quantum material called nickelate lattice which they believe could permit for direct information transfer from brains to computers. 

The scientists from Purdue University and Argonne National Laboratory in the US believe that the material would permit for the translation of the brain’s electromechanical signals into electrical activity that could be interpreted by a computer. What follows from this is the idea that a computing device could – theoretically – be built that would allow for the efficient storage (and potential transfer) of memories. Although it is still very early days, the usages to which such a breakthrough could be applied are almost limitless. At one extreme, if an external computer could analyse a brain’s output, then it might also be able to detect the early onset of neurological diseases such as Alzheimer’s or Parkinson’s. 

However, before we get too excited, it is worth remembering not only is the science behind these developments exceptionally nascent, but there are also notable moral and ethical factors to be considered. Nonetheless, we believe that the field of longevity science is one which has significant growth potential. The intersection of nanotechnology, quantum computing, artificial intelligence, molecular diagnostics and epigenetics is driving a rapid increase in investments in the field. Last year, some $800m was invested in longevity start-ups, double the level of 2017 (per Bloomberg). In the words of the late Steve Jobs, “the biggest innovations of the 21stCentury will be at the intersection of biology and technology.”


The document is provided for information purposes only and does not constitute investment advice or any recommendation to buy, or sell or otherwise transact in any investments. The document is not intended to be construed as investment research. The contents of this document are based upon sources of information which Heptagon Capital believes to be reliable. However, except to the extent required by applicable law or regulations, no guarantee, warranty or representation (express or implied) is given as to the accuracy or completeness of this document or its contents and, Heptagon Capital, its affiliate companies and its members, officers, employees, agents and advisors do not accept any liability or responsibility in respect of the information or any views expressed herein. Opinions expressed whether in general or in both on the performance of individual investments and in a wider economic context represent the views of the contributor at the time of preparation. Where this document provides forward-looking statements which are based on relevant reports, current opinions, expectations and projections, actual results could differ materially from those anticipated in such statements. All opinions and estimates included in the document are subject to change without notice and Heptagon Capital is under no obligation to update or revise information contained in the document. Furthermore, Heptagon Capital disclaims any liability for any loss, damage, costs or expenses (including direct, indirect, special and consequential) howsoever arising which any person may suffer or incur as a result of viewing or utilising any information included in this document. 

The document is protected by copyright. The use of any trademarks and logos displayed in the document without Heptagon Capital's prior written consent is strictly prohibited. Information in the document must not be published or redistributed without Heptagon Capital's prior written consent. 

Heptagon Capital LLP, 63 Brook Street, Mayfair, London W1K 4HS
tel +44 20 7070 1800
fax +44 20 7070 1881
email [email protected] 

Partnership No: OC307355 Registered in England and Wales Authorised & Regulated by the Financial Conduct Authority 

Related Insights

Featured Insights
Featured Insights22 July 2021

Season 3, Post 29: Quiz time

Your one and only question is the following: what do electric vehicles and plant-based burgers have in common? The answer: they’re both getting better the whole time. As improvements to these products occur, so adoption levels should increase. This intriguing analogy was made to us by the Chief Executive of Meatless Farm, Morten Toft Bech, […]

Learn more
Featured Insights
Featured Insights15 July 2021

Season 3, Post 28: The magic of mushrooms

Mycelium-tech could be the next big thing. You might think you are familiar with the humble mushroom. Fried, they work well as a breakfast option, for example. Alternatively, they could perhaps be chopped into a pasta dish or salad. However, when you buy mushrooms in your local store or – even better – see them […]

Learn more
Featured Insights
Featured Insights06 July 2021

Season 3, Post 27: Take a trip on the hyperloop

Imagine being able to get from central London to Edinburgh in less than an hour, or from downtown New York to San Francisco in fewer than five. Think of all that extra time you would save. Travelling the former route by train currently takes close on four hours, while, a coast-to-coast US trip might require […]

Learn more

Get The Updates

Separated they live in Bookmarks right at the coast of the famous Semantics, large language ocean Separated they live in Bookmarks right


Sign up to our monthly email newsletter for the latest fund updates, webcasts and insights.